Shares of Smith & Nephew plc (LON:SN - Get Free Report) crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 1,050.36 ($14.34) and traded as high as GBX 1,113 ($15.20). Smith & Nephew shares last traded at GBX 1,107 ($15.12), with a volume of 701,549 shares trading hands.
Smith & Nephew Trading Up 0.4%
The company has a quick ratio of 0.84, a current ratio of 2.51 and a debt-to-equity ratio of 70.22. The firm's 50 day simple moving average is GBX 1,078.66 and its two-hundred day simple moving average is GBX 1,051.34. The stock has a market cap of £12.18 billion, a P/E ratio of 40.02, a price-to-earnings-growth ratio of 0.46 and a beta of 0.62.
Insider Activity
In other news, insider Jeremy (Jez) Maiden purchased 1,855 shares of Smith & Nephew stock in a transaction dated Thursday, May 1st. The stock was bought at an average price of GBX 1,070 ($14.61) per share, with a total value of £19,848.50 ($27,104.33). Company insiders own 0.19% of the company's stock.
Smith & Nephew Company Profile
(
Get Free Report)
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
Further Reading
Before you consider Smith & Nephew, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Smith & Nephew wasn't on the list.
While Smith & Nephew currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
